$ERNA +88.90% INTRADAY — 5 Halts Already!
Low-Float Biotech on Absolute Fire Ernexa Therapeutics ($ERNA) is exploding at the open:
- Current price: $13.62 (+6.41 / +88.90%)
- 5-day gain: +264%
- Volume: 9.48 million shares (insane for a $15.76M market cap)
- Shares outstanding: only 1.17M (ultra-low float)
What’s going on?
On May 6, Ernexa released blockbuster preclinical data: ERNA-101 achieved 100% survival and complete tumor elimination in ovarian cancer models. The low-float name has been on a vertical tear ever since. Today’s surge + 5 trading halts = classic low-float momentum frenzy with retail FOMO, short covering, and pure volatility. This is not fundamentals-driven (still pre-revenue, deeply unprofitable). It’s a textbook biotech rocket fueled by news + tiny float.
— one of the most volatile names on the entire tape right now! Will $ERNA keep running or get halted again and fade? These moves can go parabolic or reverse hard in minutes. Are you watching or trading this one? Drop your bias below Not financial advice. DYOR. #ERNA #Biotech #LowFloat #Momentum #OvarianCancer
Posted May 12, 2026, 2:59 PM UTC